BACKGROUND: Animal and limited human studies hae raised concerns as to the safety of in utero exposure to mycophenolate mofetil (MMF) and sirolimus (SRL) in transplant recipients.

• 背景：通过动物实验及有限的人体研究，移植受者宫内妊娠时骁悉(MMF)或西罗莫司(SRL)暴露的安全性越来越受到关注。